BFLY | Ticker Profile - Titan Protect

BFLY

Butterfly Network, Inc.

Healthcare · Medical Devices · NYQ

$4.57

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.2B

Total market value of the company

Trailing P/E

N/A

Forward P/E

-50.59

Based on estimated future earnings — lower means cheaper

Rev Growth

+25.0%

Year-over-year revenue change

Profit Margin

-73.6%

How much profit the company keeps from each dollar of revenue

ROE

-35.2%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$5.75

+26% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 4 analysts covering this stock

About Butterfly Network, Inc.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

https://www.butterflynetwork.com

Country: United States Employees: 220 Industry: Medical Devices

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

1.232

Excellent risk-adjusted returns

Kelly Fraction

0.0693

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.598

Returns exceed worst-case losses — strong risk profile

Annual Return

115.7%

Historical annualised return based on price data

Max Drawdown

-72.4%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

2.28

Significantly more volatile than the market

52W High

$5.72

20% below the year high

52W Low

$1.32

246% above the year low

Avg Volume

4,823,877

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

12.2%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.30

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

10.33

Heavy leverage — higher financial risk if revenues decline

Current Ratio

4.03

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

2.74

Like current ratio but excludes inventory — stricter test

Gross Margin

66.1%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-50.8%

Profit from core operations before interest and tax

Free Cash Flow

$9M

Positive — the business generates more cash than it spends

Revenue (TTM)

$103M

Total revenue over the last 12 months

Net Income

$-75,774,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$6.00

Target Median

$5.75

Target Low

$5.25

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go